This site is intended for healthcare professionals
FDA Hero Banner - Multi-coloured pills and tablets
FDA Drug information

ZYPITAMAG

Read time: 1 mins
Marketing start date: 30 Apr 2024
...
 

Summary of product characteristics


Effective Time

20221017

Version

7

Spl Product Data Elements

ZYPITAMAG Pitavastatin Magnesium PITAVASTATIN PITAVASTATIN CALCIUM CARBONATE CROSPOVIDONE HYPROMELLOSE, UNSPECIFIED LACTOSE MONOHYDRATE MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED SODIUM CARBONATE TALC TITANIUM DIOXIDE off white 877 ZYPITAMAG Pitavastatin Magnesium PITAVASTATIN PITAVASTATIN CALCIUM CARBONATE CROSPOVIDONE HYPROMELLOSE, UNSPECIFIED LACTOSE MONOHYDRATE MAGNESIUM STEARATE POLYETHYLENE GLYCOL, UNSPECIFIED SODIUM CARBONATE TALC TITANIUM DIOXIDE off white 878

Application Number

NDA208379

Brand Name

ZYPITAMAG

Generic Name

Pitavastatin Magnesium

Product Ndc

70771-1117

Product Type

HUMAN PRESCRIPTION DRUG

Route

ORAL

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1117-9 Zypitamag (Pitavastatin) Tablets, 2 mg 90 Tablets Rx only NDC 70771-1117-7 Zypitamag (Pitavastatin) Tablets, 2 mg 7 Tablets Blister Carton Rx only Professional Sample-Not For Sale NDC 70771-1118-9 Zypitamag (Pitavastatin) Tablets, 4 mg 90 Tablets Rx only NDC 70771-1118-7 Zypitamag (Pitavastatin) Tablets, 4 mg 7 Tablets Blister Carton Rx only Professional Sample-Not For Sale image image image image

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.